Bentham Science Logo

Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued)

Volume 2, 2 Issues, 2015
ISSN: 2212-7046 (Online)
ISSN: 2212-7038 (Print)
This journal supports open access

Contents

Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued), Volume 1 - Number 1




Quilizumab is an Afucosylated Humanized Anti-M1 Prime Therapeutic Antibody

, 1(1): 24 - 31

Hans D. Brightbill, Yuwen L. Lin, Zhonghua Lin, Martha Tan, Y. Gloria Meng, Mercedesz Balazs, Shan Chung and Lawren C. Wu


DOI: 10.2174/22127038114019990003




Activin-A: A New Piece in the Puzzle of Tolerance in Asthma

, 1(1): 45 - 56

Sofia Tousa, Maria Semitekolou, Ioannis Morianos, Aikaterini I Trochoutsou and Georgina Xanthou


DOI: 10.2174/2212703801666140221004020


Hydrogen Sulfide: A New Tool to Design and Develop Drugs

, 1(1): 57 - 66

Nethaji Muniraj, Abel Damien Ang, Alireza Badiei, Jack Rivers-Auty and Madhav Bhatia


DOI: 10.2174/2212703801666140311005131



Editor-in-Chief

Giovanni Passalacqua
Department of Internal Medicine, Allergy & Respiratory Diseases
University of Genova
Genova
(Italy)

View Full Editorial Board

Advertisement

How to write and publish your papers in high impact journalsPLANNING YOUR RESEARCH TO PUBLISH IN HIGH IMPACT JOURNALSCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog